Testosterone deficiency (TD) has become a frequently diagnosed condition in our current
society with an obesity epidemic. Men diagnosed with TD often have co-morbidities …

Testosterone deficiency (TD) is a well-established and recognized medical condition that
contributes to several co-morbidities, including metabolic syndrome, visceral obesity and …

Testosterone and its metabolite, 5α-dihydrotestosterone are critical metabolic and vascular
hormones, which regulate a host of biochemical pathways including carbohydrate, lipid and …

Introduction Low testosterone (T) levels are associated with obesity, metabolic syndrome,
type 2 diabetes mellitus and altered lipid profiles, thus contributing to increased …

In the adult male, testosterone (T) deficiency (TD) also known as male hypogonadism, is a
well-established medical condition, which has been recognized for more than a century. T …

Low levels of testosterone are manifested by erectile dysfunction, reduced sexual desire,
and loss of morning erections with increasing numbers of men are being diagnosed and …

Testosterone is the main male sex hormone and is essential for the maintenance of male
secondary sexual characteristics and fertility. Androgen deficiency in young men owing to …

Background/objectives Long-term testosterone therapy (TTh) in men with hypogonadism
has been shown to improve all components of the metabolic syndrome. In this study, we …

Since November 2013, there has been a flurry of articles written in the media touting the risk
of cardiovascular (CV) disease in men treated with testosterone, based on two recent …

Obesity, hypertension, insulin resistance (IR), dyslipidaemia, impaired coagulation profile
and chronic inflammation characterize cardiovascular risk factors in men. Adipose tissue is …